Real-World Long-Term Effectiveness and Safety Outcomes Among Patients Receiving Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
Year: 2025
Type: article
Authors: Carlyn Rose Tan, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Kylee MacLachlan, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Sridevi Rajeeve, Hamza Hashmi, Gunjan Shah, Michael Scordo, Heather Landau, Sergio Giralt, Alexander Lesokhin, Neha Korde, Francesco Maura, Maximilian Merz, Gilbert Ko, Niodita Gupta-Werner, Jessica Fowler, Saad Usmani
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414303252